Met Life Investment Management, LLC Applied Therapeutics Inc. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 56,302 shares of APLT stock, worth $489,264. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,302
Previous 24,578
129.07%
Holding current value
$489,264
Previous $114,000
319.3%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding APLT
# of Institutions
140Shares Held
112MCall Options Held
1.68MPut Options Held
1.91M-
Janus Henderson Group PLC London, X010.5MShares$91.6 Million0.05% of portfolio
-
Morgan Stanley New York, NY9.9MShares$86.1 Million0.01% of portfolio
-
Vr Adviser, LLC New York, NY9.83MShares$85.4 Million8.65% of portfolio
-
Perceptive Advisors LLC New York, NY8.01MShares$69.6 Million1.78% of portfolio
-
Franklin Resources Inc San Mateo, CA6.8MShares$59.1 Million0.02% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $417M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...